Grace Therapeutics Ownership | Who Owns Grace Therapeutics?

Grace Therapeutics Ownership Summary

Grace Therapeutics is owned by 34.97% institutional investors, 38.39% insiders, and 26.64% retail investors.

GRCE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Grace Therapeutics	34.97%	38.39%	26.64%
Sector	Healthcare Stocks	278.70%	10.61%	-189.31%
Industry	Biotech Stocks	63.84%	10.66%	25.50%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	17	13.33%	4,024,092	92.74%	34	10.62%	8	-42.86%	7	600.00%
Dec 31, 2024	15	1400.00%	2,087,880	117.58%	18	26.09%	14	1300.00%	1	-
Sep 30, 2024	1	-	959,571	-	8	-	1	-	-	-

GRCE Ownership FAQ

Who Owns Grace Therapeutics?

Grace Therapeutics shareholders are primarily institutional investors at 34.97%, followed by 38.39% insiders and 26.64% retail investors. The average institutional ownership in Grace Therapeutics's industry, Biotech Stocks , is 63.84%, which Grace Therapeutics falls below.

Does Blackrock own Grace Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Grace Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools